Cover Image
市場調查報告書

男性不孕症:全球臨床實驗檢討

Male Infertility Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 319588
出版日期 內容資訊 英文 80 Pages
訂單完成後即時交付
價格
Back to Top
男性不孕症:全球臨床實驗檢討 Male Infertility Global Clinical Trials Review, H2, 2014
出版日期: 2014年11月17日 內容資訊: 英文 80 Pages
簡介

本報告提供男性不孕症的臨床試驗相關的基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,臨床試驗的主要製藥企業及研究機關簡介等資料。

簡介

  • 男性不孕症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5個國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:男性疾病治療藥臨床實驗上男性不孕症所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:男性疾病治療藥臨床實驗上男性不孕症所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

男性不孕症治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Pfizer Inc.
    • Repros Therapeutics Inc.
    • Eli Lilly and Company
    • Intas Pharmaceuticals Ltd.
    • Fertility North Pty Limited
    • E. Merck KG
    • Cosmo Pharmaceuticals S.p.A
    • CATALYSIS, S.L.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development
    • Assistance Publique - Hopitaux de Paris
    • Hadassah Medical Organization
    • Shahid Beheshti University
    • Tabriz University of Medical Sciences
    • Yale University
    • National Institute of Environmental Health Sciences
    • Instituto Valenciano de Infertilidad
    • The University of Hong Kong
    • University of Washington

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2364CTIDB

GlobalData's clinical trial report, "Male Infertility Global Clinical Trials Review, H2, 2014" provides data on the Male Infertility clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Male Infertility. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Male Infertility. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Male Infertility
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Male Infertility to Male Health Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Male Infertility to Male Health Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Male Infertility
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Male Infertility Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Repros Therapeutics Inc.
      • Clinical Trial Overview of Repros Therapeutics Inc.
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Intas Pharmaceuticals Ltd.
      • Clinical Trial Overview of Intas Pharmaceuticals Ltd.
      • Fertility North Pty Limited
      • Clinical Trial Overview of Fertility North Pty Limited
      • E. Merck KG
      • Clinical Trial Overview of E. Merck KG
      • Cosmo Pharmaceuticals S.p.A
      • Clinical Trial Overview of Cosmo Pharmaceuticals S.p.A
      • CATALYSIS, S.L.
      • Clinical Trial Overview of CATALYSIS, S.L.
    • Clinical Trial Overview of Top Institutes / Government
      • Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • Hadassah Medical Organization
      • Clinical Trial Overview of Hadassah Medical Organization
      • Shahid Beheshti University
      • Clinical Trial Overview of Shahid Beheshti University
      • Tabriz University of Medical Sciences
      • Clinical Trial Overview of Tabriz University of Medical Sciences
      • Yale University
      • Clinical Trial Overview of Yale University
      • National Institute of Environmental Health Sciences
      • Clinical Trial Overview of National Institute of Environmental Health Sciences
      • Instituto Valenciano de Infertilidad
      • Clinical Trial Overview of Instituto Valenciano de Infertilidad
      • The University of Hong Kong
      • Clinical Trial Overview of The University of Hong Kong
      • University of Washington
      • Clinical Trial Overview of University of Washington
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Male Infertility Therapeutics, Global, Clinical Trials by Region, 2014*
  • Male Infertility Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Male Infertility Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Male Infertility Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Male Infertility Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Male Infertility Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Male Infertility Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Male Infertility Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Male Infertility to Male Health Clinical Trials, G7 Countries (%), 2014*
  • Male Infertility Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Male Infertility Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Male Infertility to Male Health Clinical Trials, E7 Countries (%), 2014*
  • Male Infertility Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Male Infertility Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Male Infertility Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Male Infertility Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Male Infertility Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Male Infertility Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Male Infertility Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Male Infertility Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Male Infertility Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Male Infertility Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Male Infertility Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Male Infertility Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Male Infertility Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Male Infertility Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Male Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Male Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Repros Therapeutics Inc., 2014*
  • Male Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Male Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Intas Pharmaceuticals Ltd., 2014*
  • Male Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Fertility North Pty Limited, 2014*
  • Male Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2014*
  • Male Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Cosmo Pharmaceuticals S.p.A, 2014*
  • Male Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by CATALYSIS, S.L., 2014*
  • Male Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014*
  • Male Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*
  • Male Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014*
  • Male Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University, 2014*
  • Male Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University of Medical Sciences, 2014*
  • Male Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014*
  • Male Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Environmental Health Sciences, 2014*
  • Male Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by Instituto Valenciano de Infertilidad, 2014*
  • Male Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2014*
  • Male Infertility Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014*

List of Figures

  • Male Infertility Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Male Infertility Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Male Infertility Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Male Infertility Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Male Infertility Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Male Infertility Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Male Infertility Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Male Infertility Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Male Infertility to Male Health Clinical Trials, G7 Countries (%), 2014*
  • Male Infertility Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Male Infertility Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Male Infertility to Male Health Clinical Trials, E7 Countries (%), 2014*
  • Male Infertility Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Male Infertility Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Male Infertility Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Male Infertility Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Male Infertility Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Male Infertility Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Male Infertility Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Male Infertility Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Male Infertility Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Male Infertility Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Male Infertility Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top